Finance

Lists
Why is SNOA up 3,45%?
Dive Deeper
SNOA:NASDAQ
Sonoma Pharmaceuticals Inc
1,20 USD
+3,45%
(+0,040) 1D
9-окт., 13:30:29 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SNOA...
Open
1,16 USD
High
1,20 USD
Low
1,16 USD
Mkt. cap
5,75 млн
Avg. vol.
52,03 миң
Volume
17,15 миң
52-wk high
4,30 USD
52-wk low
0,85 USD
EPS
-1,22 USD
Beta
1,30
Shares outstanding
4,79 млн
No. of employees
260
Open
1,16 USD
High
1,20 USD
Low
1,16 USD
Mkt. cap
5,75 млн
Avg. vol.
52,03 миң
Volume
17,15 миң
52-wk high
4,30 USD
52-wk low
0,85 USD
EPS
-1,22 USD
Beta
1,30
Shares outstanding
4,79 млн
No. of employees
260
News stories
From web sources and news partners
About Sonoma Pharmaceuticals Inc
CEO-
Employees260
Founded1999
HeadquartersБоулдер, Колорадо, Америка Кошмо Штаттары
SectorPharmaceutical industry
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
5,60 млн
4,35 млн
5,56 млн
6,41 млн
Cost of goods sold
3,48 млн
2,70 млн
3,38 млн
3,83 млн
Cost of revenue
3,48 млн
2,70 млн
3,38 млн
3,83 млн
Research and development expenses
575,00 миң
557,00 миң
545,00 миң
597,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,88 млн
1,77 млн
1,99 млн
2,02 млн
Operating expense
2,46 млн
2,33 млн
2,53 млн
2,62 млн
Total operating expenses
5,94 млн
5,03 млн
5,91 млн
6,45 млн
Operating income
-337,00 миң
-678,00 миң
-351,00 миң
-40,00 миң
Other non operating income
-394,00 миң
-271,00 миң
-1,59 млн
-
EBT including unusual items
-731,00 миң
-949,00 миң
-497,00 миң
-330,00 миң
EBT excluding unusual items
-731,00 миң
-949,00 миң
-497,00 миң
-330,00 миң
Income tax expense
-197,00 миң
-130,00 миң
84,00 миң
-
Effective tax rate
26,95%
13,70%
-16,90%
-
Other operating expenses
-
-
-
-
Net income
-534,00 миң
-819,00 миң
-581,00 миң
-330,00 миң
Net profit margin
-9,53%
-18,83%
-10,45%
-5,15%
Earnings per share
-
-0,48
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-301,00 миң
-644,00 миң
-318,00 миң
-8,00 миң
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору